Join us for an informative webinar with Dr. Nadeem Khaliq of Catalyst Pharmaceuticals and Dr. Kaitlin Batley of Children’s Health Specialty Center, Dallas. This webinar will provide an overview of the ongoing AGAMREE® (vamorolone) SUMMIT Study, which examines the real-world impact of AGAMREE on the progression of Duchenne muscular dystrophy. Dr. Batley will highlight what this study means to patients with Duchenne and their caregivers and address frequently asked questions to help you better understand the study. Don’t miss this opportunity to learn more about the SUMMIT Study!
Shaping the Future: The Vamorolone Summit Study
June 12, 2025
1 pm ET | 12pm CT | 11am MT | 10am PT
Guest Speakers
Dr. Kaitlin Batley is a Pediatric Neuromuscular Neurologist and the Director of the Pediatric Neuromuscular Program at UT Southwestern (UTSW) and Children’s Health in Dallas, TX. After completing Child Neurology residency and Pediatric Neuromuscular fellowship at UTSW, Dr. Batley then joined faculty as an Assistant Professor of Pediatrics and Neurology, also serving as the Pediatric Neuromuscular Fellowship Director. She oversees clinical operations and manages a multidisciplinary team to provide care to children affected by neuromuscular disorders and their families. Dr. Batley is also involved in research, participating in over 20 clinical trials and natural history studies.
Dr. Khaliq received his medical degree from Allama Iqbal Medical College, Lahore. He has 20+ years of global Clinical Operations (CO) experience in various roles at AbbVie Inc. Alexion, Baxter Inc. and PPD Inc. Most of his recent clinical research experience comprises of Neuroscience, Stem Cell Therapy, Oncology, and Transplant Surgery. Dr. Khaliq has comprehensive knowledge of ICH/GCP guidelines and has managed multiple national and global clinical trials ranging from Phase I–IV. In his current role, Dr. Khaliq oversees all clinical operational activities at Catalyst.
